Search

Your search keyword '"Koh, Han Seok"' showing total 10 results
Start Over Author "Koh, Han Seok"
10 results on '"Koh, Han Seok"'

10. Targeting MicroRNA-485-3p Blocks Alzheimer's Disease Progression.

Author

Koh, Han Seok, Lee, SangJoon, Lee, Hyo Jin, Min, Jae-Woong, Iwatsubo, Takeshi, Teunissen, Charlotte E., Cho, Hyun-Jeong, and Ryu, Jin-Hyeob

Subjects
*ALZHEIMER'S disease, *DISEASE progression, *COGNITION disorders, *LABORATORY mice, *DEMENTIA, *CEREBROSPINAL fluid, *PHAGOCYTOSIS
Abstract

Alzheimer's disease (AD) is a form of dementia characterized by progressive memory decline and cognitive dysfunction. With only one FDA-approved therapy, effective treatment strategies for AD are urgently needed. In this study, we found that microRNA-485-3p (miR-485-3p) was overexpressed in the brain tissues, cerebrospinal fluid, and plasma of patients with AD, and its antisense oligonucleotide (ASO) reduced Aβ plaque accumulation, tau pathology development, neuroinflammation, and cognitive decline in a transgenic mouse model of AD. Mechanistically, miR-485-3p ASO enhanced Aβ clearance via CD36-mediated phagocytosis of Aβ in vitro and in vivo. Furthermore, miR-485-3p ASO administration reduced apoptosis, thereby effectively decreasing truncated tau levels. Moreover, miR-485-3p ASO treatment reduced secretion of proinflammatory cytokines, including IL-1β and TNF-α, and eventually relieved cognitive impairment. Collectively, our findings suggest that miR-485-3p is a useful biomarker of the inflammatory pathophysiology of AD and that miR-485-3p ASO represents a potential therapeutic candidate for managing AD pathology and cognitive decline. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results